<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
  <journal-id journal-id-type="publisher-id">59</journal-id>
  <journal-id journal-id-type="short-title">giidr</journal-id>
  <journal-id journal-id-type="doi">10.31703/giidr</journal-id>
  <journal-title-group>
    <journal-title>Global Immunological &amp; Infectious Diseases Review</journal-title>
    <abbrev-journal-title abbrev-type="publisher">giidr</abbrev-journal-title>
  </journal-title-group>
  <issn publication-format="print">2788-4961</issn>
  <issn publication-format="electronic">2788-418X</issn>
  <self-uri xlink:href="https://giidrjournal.com"/>
  <publisher>
    <publisher-name>Humanity Publications</publisher-name>
    <publisher-loc>Pakistan</publisher-loc>
  </publisher>
</journal-meta>
<article-meta>
  <article-id pub-id-type="publisher-id">395108</article-id>
  <article-id pub-id-type="doi">10.31703/giidr.2024(IX-I).04</article-id>
  <article-id pub-id-type="other" specific-use="submission-id">5575</article-id>
  <article-version article-version-type="publisher">1.0</article-version>
  <article-categories>
    <subj-group subj-group-type="heading">
      <subject>article</subject>
    </subj-group>
  </article-categories>
  <title-group>
    <article-title xml:lang="en">Prevalence and Associated Risk Factors of Cardiovascular Disease among Type 2 Diabetes Patients in Lower Dir Pakistan</article-title>
  </title-group>
<contrib-group>
  <contrib contrib-type="author" seq="1" corresp="yes">
    <name>
      <surname>Khan</surname>
      <given-names>Zahid</given-names>
    </name>
    <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
    <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
    <xref ref-type="aff" rid="aff1"/>
    <xref ref-type="corresp" rid="cor1"/>
  </contrib>
  <contrib contrib-type="author" seq="2">
    <name>
      <surname>Ullah</surname>
      <given-names>Usman</given-names>
    </name>
    <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
    <xref ref-type="aff" rid="aff2"/>
  </contrib>
  <contrib contrib-type="author" seq="3">
    <name>
      <surname>Sultan</surname>
      <given-names>Ayesha</given-names>
    </name>
    <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
    <xref ref-type="aff" rid="aff3"/>
  </contrib>
  <contrib contrib-type="author" seq="4">
    <name>
      <surname>Iqbal</surname>
      <given-names>Uzma</given-names>
    </name>
    <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
    <xref ref-type="aff" rid="aff4"/>
  </contrib>
  <contrib contrib-type="author" seq="5">
    <name>
      <surname>Rizwan</surname>
      <given-names>Muhammad</given-names>
    </name>
    <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
    <xref ref-type="aff" rid="aff5"/>
  </contrib>
  <aff id="aff1">
    <label>1</label>
    <institution-wrap>
      <institution>Department of Statistics, University of Malakand</institution>
    </institution-wrap>
    <named-content content-type="author-role">Lecturer</named-content>
    <addr-line>KP</addr-line>
    <country>Pakistan</country>
  </aff>
  <aff id="aff2">
    <label>2</label>
    <institution-wrap>
      <institution>School of Mathematics and Statistics, Nanjing University of Science and Technology</institution>
    </institution-wrap>
    <named-content content-type="author-role">MPhil Scholar</named-content>
    <addr-line>Jiangsu</addr-line>
    <country>China</country>
  </aff>
  <aff id="aff3">
    <label>3</label>
    <institution-wrap>
      <institution>Department of Statistics, Virtual University</institution>
    </institution-wrap>
    <named-content content-type="author-role">Lecturer</named-content>
    <addr-line>Islamabad</addr-line>
    <country>Pakistan</country>
  </aff>
  <aff id="aff4">
    <label>4</label>
    <institution-wrap>
      <institution>National College of Business Administration and Economics, Lahore</institution>
    </institution-wrap>
    <addr-line>Punjab</addr-line>
    <country>Pakistan</country>
  </aff>
  <aff id="aff5">
    <label>5</label>
    <institution-wrap>
      <institution>Undergraduate, Department of Statistics, University of Malakand, Chakdara</institution>
    </institution-wrap>
    <addr-line>KP</addr-line>
    <country>Pakistan</country>
  </aff>
</contrib-group>
<author-notes>
  <corresp id="cor1">Corresponding Author: Zahid Khan, Lecturer, Department of Statistics, University of Malakand, KP, Pakistan.</corresp>
<fn fn-type="COI-statement" id="fn-coi">
  <p>The authors declare that they have no conflicts of interest.</p>
</fn>
<fn fn-type="ethics-statement" id="fn-ethics">
  <p>This study did not require formal ethics approval.</p>
</fn>
<fn fn-type="data-availability-statement" id="fn-data">
  <p>Data sharing is not applicable to this article.</p>
</fn>
</author-notes>
<pub-date pub-type="epub" date-type="pub" publication-format="electronic">
  <day>31</day>
  <month>03</month>
  <year>2024</year>
</pub-date>
<pub-date pub-type="collection">
  <month>03</month>
  <year>2024</year>
</pub-date>
<pub-date date-type="pub" publication-format="print">
  <day>23</day>
  <month>05</month>
  <year>2024</year>
</pub-date>
  <volume>9</volume>
  <issue>1</issue>
  <season>Winter</season>
  <fpage>28</fpage>
  <lpage>33</lpage>
  <history>
    <date date-type="accepted">
      <day>23</day>
      <month>05</month>
      <year>2024</year>
    </date>
  </history>
<funding-group>
  <funding-statement>
<p>The authors received no specific funding for this work.</p>
  </funding-statement>
</funding-group>
<permissions>
  <copyright-year>2024</copyright-year>
  <copyright-holder>Humanity Publications</copyright-holder>
  <license license-type="open-access" xml:lang="en" xlink:href="https://creativecommons.org/licenses/by/4.0/">
    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License.</license-p>
  </license>
</permissions>
<self-uri content-type="text/html" xlink:href="https://giidrjournal.com/article/prevalence-and-associated-risk-factors-of-cardiovascular-disease-among-type-2-diabetes-patients-in-lower-dir-pakistan"/>
<self-uri content-type="pdf" xlink:href="https://giidrjournal.com/pdf/giidr/FpOlz9KwB6.pdf"/>
<supplementary-material id="suppl-pdf" content-type="pdf" xlink:href="https://giidrjournal.com/pdf/giidr/FpOlz9KwB6.pdf">
  <label>PDF</label>
  <caption>
    <title>Full Text PDF</title>
  </caption>
</supplementary-material>
  <abstract>
    <p>One of the most prevalent complications of type 2 diabetes mellites (T2DM) is cardiovascular disease (CVD) which is themajor cause of death. This study aims to assess the incidence and associated risk factors of CVD among T2DM patients at selected hospitals of Tehsil Adenzia, District Lower Dir. A structured questionnaire is designed for the collection of data from type 2 diabetic patients. A total of 1360 subjects are selected from the study area. Data is analyzed by Minitab version 19. The prevalence of CVD among T2DM is 20.04% in the selected sample. The logistic regression model is used to identify factors associated with CVD in diabetic patients. The model shows that higher  age, duration of T2DM, and treatment taken are significant risk factors for CVD among T2DM patients.</p>
  </abstract>
<kwd-group kwd-group-type="author-keywords">
  <kwd>Cardiovascular disease</kwd>
  <kwd>Type 2 diabetes mellitus</kwd>
  <kwd>higher age</kwd>
  <kwd>duration of T2DM</kwd>
  <kwd>treatment type.</kwd>
</kwd-group>
  <custom-meta-group>
    <custom-meta><meta-name>views</meta-name><meta-value>388</meta-value></custom-meta>
    <custom-meta><meta-name>downloads</meta-name><meta-value>0</meta-value></custom-meta>
    <custom-meta><meta-name>html-views</meta-name><meta-value>0</meta-value></custom-meta>
    <custom-meta><meta-name>google-scholar-citations</meta-name><meta-value>0</meta-value></custom-meta>
    <custom-meta><meta-name>crossref-citations</meta-name><meta-value>0</meta-value></custom-meta>
  </custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec-1">
  <title>Introduction</title>
<p>Diabetes Mellitus (DM) is on the list of more severe diseases in terms of public health hazards worldwide. World Health Organization (WHO) reported that the incidence of type 2 diabetes mellitus (T2DM) increased rapidly in the last three decades globally (WHO, 2021). According to the IDF report the prevalence of T2DM in adults aged from 20 to 79 is 537 million. Moreover, their report reveals that one in every ten adults is suffering from T2DM. This prevalence rate is to be increasing rapidly in the near future.</p><p>T2DM has many complications, most of which are chronic. Cardiovascular disease (CVD) is one of the common complications of T2DM (Tracey et al., 2016). Similar to T2DM, the prevalence of cardiovascular disease (CVD) is rapidly increasing in the world. It is evident that diabetes is an independent risk factor for CVD. Diabetic patients are more prone to CVD than non-diabetic (Gu, CC and MI, 1999; Haffner, Cassells, 2003).</p><p>The prevalence of CVD in diabetic patients is an alarming point, as it is a major reason for premature disability, morbidity, mortality, and hospitalization (Khwaja et al.2007; Khwaja et al.2004). Type 2 diabetic patients with CVD complications have 2 to 8 times higher chances of mortality than those who have CVD without type 2 diabetes.  (Malmberg, Yusuf and Gerstein, 2000). Moreover, the long duration of diabetes leads to the incidence of CVD in subjects already suffering from diabetes (Branch, et al., 2019; Petrie, Guzik, &amp; Touyz, 2018; Hayward et al., 2015)</p><p>Yao et al. (2023) conducted a study on the prevalence of CVD and its association factors. In their study, a total of 1765 diabetic patients are selected to examine the risk factors of CVD in diabetic subjects, such as long duration of diabetes, age, hyperlipidemia, and hypertension. They found a significant association between the prevalence of CVD and diabetes duration, age at diagnosis, hyperlipidemia, and hypertension.  Raza et al. (2019) investigated significant factors associated with the incidence of CVD in diabetic patients. They point out that one of the associated risk factors is age greater than 40 years. Tamiru et al. (2010) determined the prevalence of cardiovascular risk factors in diabetic patients at the diabetic clinic of Jimma University Specialized Hospital. Canto et al. (2019) conducted a study on the complication of type 2 diabetes. According to their study, CVD is the major complication of type 2 diabetes.  Wang et al. (2021) explore that the major risk factors for coronary heart disease (CHD) in patients with type 2 diabetes are obesity and hypertension. They used a multivariate logistic regression model for such analysis.  Lehto et al. (2000) investigated that hyperlipidemia, obesity, smoking, hypertension, and other cardiovascular risk factors are commonly clustered in patients with diabetes.</p><p>Regassa, Tola, and Ayele (2021) investigated the incidence and significant risk factors associated with T2DM subjects.</p><p>Their study shows a 42.51% incidence of CVD in diabetic patients. They used a logistic regression model for assessing the risk factors. The model shows that higher age, obesity, hypertension, drinking alcohol, and experiencing microvascular diabetic complications were significant risk factors for the incidence of CVD among T2DM patients. Matheus et al. (2013) described the association between oxidative stress, poor glycemic control, markers of insulin resistance, and low-grade inflammation that have been suggested as putative factors linking DM and CVD.</p><p>Leon and Maddox (2015) pointed out that diabetes patients face some of the associated risk factors of CVD like dyslipidemia, hypertension, and obesity placing them at increased risk for cardiac events. They claimed that biological mechanisms associated with DM independently increase the risk of CVD in diabetic patients.</p><p>Einarson et al. (2018) reviewed the ten-year literature regarding the incidence of CVD among T2DM patients. They found that CVD affects approximately 32.2% of all persons with T2DM, globally. Moreover, they concluded that CVD leads to mortality among T2DM patients, accounting for approximately half of all deaths over the study period.</p><p>Some studies on the incidence of various diseases are conducted in the District Dir Lower, Khyber Pakhtunkhwa (Khan et al., 2022a; Haq et al., 2024; Haq et al., 2022;). This study investigates the incidence of CVD among T2DM patients. Moreover, the risk factors of CVD as a complication of TD2M are assessed. In past the studies have been conducted on T2DM in the study area (Akhtar et al., 2016; Khan et al. 2022b). However, they have assessed only the prevalence and complications of T2DM.</p>
</sec>
<sec id="sec-2">
  <title>Material and Method</title>
<p>The present study determines the risk factors for the incidence of CVD among T2DM patients in Gulabad Hospital Gulabad and Tehsil Head Quarter Hospital Chakdara. A structured questionnaire is used to collect data from T2DM patients visiting to these hospitals. Minitab version 19 is used to analyze the collected data. The binary logistic regression model is used to identify the significant risk factors associated with the incidence of CVD among T2DM patients.  The logistic regression model is effective when the response variable is categorical (Khan, Hussain, Ijaz, 2022; Khan, Haq, &amp; Ali, 2022; Khan et al., 2022; Khan et al., 2022a; Khan et al. 2022b). The dependent variable which is the prevalence of CVD among T2DM patients is binary in nature, that is, whether the respondent has the CVD complication of diabetes or not.</p>
</sec>
<sec id="sec-3">
  <title>Results</title>
<p>A sample of size 1360 is selected from the hospitals. Table 1 shows that the sample consists of 982 (72.22%) male and 378 (27.78%) female subjects. The prevalence of CVD is 20.07% among diabetic patients.</p><p>Table 1 further reveals that 204 (15.14%) of patients take proper treatment for diabetes, while 640 (47.051%) have not taken such treatment. Moreover, 506 (37.20%) are uncertain about taking proper treatment. These figures show that most of the diabetic people in the study area are not taking proper treatment for diabetes. Moreover, the Table shows that 280 (20.58%) patients have had diabetes from the last 1 to 4 years, 670 (49.26%) subjects prevalent to diabetes from 5 to 8 years, 410 (30.14%) persons suffering from diabetes from 8 years or above. In the study area, half of the diabetic population suffers from diabetes from 5 to 8 years.</p>
</sec>
<sec id="sec-4">
  <title>Table 1 Some Characteristics of Selected Subjects</title>
<table-wrap id="table1"><label>Table 1</label><caption><title>Table 1</title></caption><table><tbody><tr><td valign="bottom"> <p><bold>Characteristic</bold></p> </td><td valign="bottom"> <p><bold>Category </bold></p> </td><td> <p><bold>No. of Subjects</bold></p> </td><td> <p><bold>Percentage</bold></p> </td></tr><tr><td valign="bottom"> <p>Gender</p> </td><td valign="bottom"> <p>Male</p> </td><td> <p>982</p> </td><td> <p>72.21</p> </td></tr><tr><td valign="bottom"></td><td valign="bottom"> <p>Female</p> </td><td> <p>378</p> </td><td> <p>27.79</p> </td></tr><tr><td valign="bottom"> <p>Prevalence of CVD</p> </td><td valign="bottom"> <p>yes</p> </td><td> <p>273</p> </td><td> <p>20.07</p> </td></tr><tr><td valign="bottom">  </td><td valign="bottom"> <p>No</p> </td><td> <p>1087</p> </td><td> <p>79.92</p> </td></tr><tr><td valign="bottom"> <p>Proper Treatment</p> </td><td valign="bottom"> <p>Yes</p> </td><td> <p>204</p> </td><td> <p>15.14</p> </td></tr><tr><td valign="bottom"></td><td valign="bottom"> <p>No</p> </td><td> <p>640</p> </td><td> <p>47.05</p> </td></tr><tr><td valign="bottom"></td><td valign="bottom"> <p>Uncertain</p> </td><td> <p>506</p> </td><td> <p>37.20</p> </td></tr><tr><td valign="bottom"> <p>Duration of
  Diabetes</p> </td><td valign="bottom"> <p>1-4 years</p> </td><td> <p>280</p> </td><td> <p>20.58</p> </td></tr><tr><td valign="bottom"></td><td valign="bottom"> <p>5-8 years</p> </td><td> <p>670</p> </td><td> <p>49.26</p> </td></tr><tr><td valign="bottom"></td><td valign="bottom"> <p>&gt; 8 years</p> </td><td> <p>410</p> </td><td> <p>30.14</p> </td></tr></tbody></table></table-wrap>  <p><break/></p> <p>Figure
1 reveals that 604 (44%) subjects have aged from 23 to 32, 264(19%) have aged
from 33 to 42, 264 (19%) have from 43 to 52, and 75(6%) from age 53 to 62,
151(11%) have age 62 and above. Thus, the majority of selected subjects are of
young age, that is, from 23 to 42 years.</p> <p><break/></p>
</sec>
<sec id="sec-5">
<p>Figure 1 reveals that 604 (44%) subjects have aged from 23 to 32, 264(19%) have aged from 33 to 42, 264 (19%) have from 43 to 52, and 75(6%) from age 53 to 62, 151(11%) have age 62 and above. Thus, the majority of selected subjects are of young age, that is, from 23 to 42 years.</p>
</sec>
<sec id="sec-6">
<p>Figure 2 reveals the monthly income of the respondents. Both the number of respondents and frequency along with income level are shown. The Figure shows that the majority of the subjects have an income range from Rs. 36000 to Rs. 47999.</p><p><break/></p><p>Figure 2</p><p>Income of the respondents</p><p>The binary logistic regression model is used due to the categorical nature of the response variable, that is, the prevalence of CVD among diabetic patients which has two categories, yes and no, that is, whether the respondent has a prevalence of CVD or not. Table 2 reveals the result of the fitted binary logistic regression model. The Table shows that age, duration of diabetes, and taking proper treatment are significantly associated with the incidence of CVD among T2DM patients</p>
</sec>
<sec id="sec-7">
  <title>Table 2 Result of Fitted Binary Logistic Regression Model</title>
<table-wrap id="table2"><label>Table 2</label><caption><title>Table 2</title></caption><table><tbody><tr><td valign="top">  </td><td> <p><bold>Coefficient</bold></p> </td><td> <p><bold>SE of Co-efficient</bold></p> </td><td> <p><bold>VIF</bold></p> </td><td> <p><bold>P Value</bold></p> </td></tr><tr><td valign="top"> <p>Constant</p> </td><td> <p>-4.70</p> </td><td> <p>1.9000</p> </td><td>  </td><td>  </td></tr><tr><td valign="top"> <p>Higher Age</p> </td><td> <p>0.1238</p> </td><td> <p>0.0535</p> </td><td> <p>2.64</p> </td><td> <p>0.002</p> </td></tr><tr><td valign="top"> <p>Long Duration</p> </td><td> <p>2.286</p> </td><td> <p>0.9850</p> </td><td> <p>4.16</p> </td><td> <p>0.050</p> </td></tr><tr><td valign="top"> <p>No proper Treatment</p> </td><td> <p>2.052</p> </td><td> <p>0.8340</p> </td><td> <p>2.11</p> </td><td> <p>0.001</p> </td></tr></tbody></table></table-wrap><p><italic>R-square = 0.32</italic></p>
</sec>
<sec id="sec-8">
  <title>Discussion</title>
<p>CVD among diabetic patients is prevalent in the study area. The risk factors associated with CVD among diabetic patients are increasing age, long duration of diabetes, and taking no proper treatment.</p><p>Diabetic patients are more prone to CVD as their age increases. This result is similar to Dal et al. (2019).  According to the report of the Centers for Disease Control and Prevention (2011) increasing age is leading to the death of CVD patients with diabetes. Further, in the USA 68% of such patients having aged greater than 65 died. This indicates the higher ratio of death of CVD diabetic subjects due to increasing age.</p><p>In our study, the majority (approximately 50%) of the subjects have a 5 to 8-year duration of diabetes. In addition, 30% of the subjects suffered from diabetes for more than 8 years. This duration is considered long which is an alarming point for the people of the study area.  According to Zoungas et al. (2014), the duration of diabetes causes atherosclerotic lesions, including intimal thickness and thin cap fibroatheromas, which lead to deleterious effects on small and large vessels and cause the incidence of CVD. Thus, those diabetic patients who have suffered from such diseases for a long are more prone to CVD. This result is a match to Branch et al. (2019), Petrie, Guzik, and Touyz (2018), and Hayward et al. (2015). Moreover, Yao et al. (2023) mentioned the long duration of diabetes is one of the main risk factors for the incidence of CVD.</p><p>Effective treatment of T2DM is crucial because it is the major risk factor of CVD which is the prevalent cause of mortality and morbidity. In our study, another significant factor associated with the incidence of CVD among diabetic patients is taking no proper treatment of diabetes. The patient who takes the diabetes disease light are more prone to CVD. T2DM can be controlled by proper treatment which may lead to reduce the prevalence of CVD, as T2DM is the risk factor of CVD. However, the relationship between treating DM and reducing CV is complex, because CVD-associated risk factors including hypertension, obesity, and dyslipidemia are prevalent in diabetic patients.  Some researchers proved that several factors including increased oxidative stress, increased coagulability, endothelial dysfunction, and autonomic neuropathy are often present in patients with DM and may directly contribute to the development of CVD (Matheus et al., 2013). Our study showed a higher proportion of subjects are not taking proper treatment of DT2M. Thus, approximately half of the diabetic patients are not taking proper treatment. This may lead to chronic complications of T2DM including CVD which is the major cause of mortality.</p><p><break/></p><p><bold>Conclusion</bold></p><p>This study shows the 20.04% incidence of CVD among T2DM patients in selected hospitals of tehsil Adenzia, district Lower Dir. The risk factors for the incidence of CVD in T2DM are increasing age, long duration of diabetes, and no proper treatment of T2DM. In order to minimize the risk of CVD in T2DM adults, the proper treatment of T2DM should be ensured. Moreover, special care should be taken for those subjects who have suffering from T2DM for a long time and have a higher age. T2DM patients should be aware of the complications of diabetes. The present study can be extended by increasing the sample size in the study area.</p>
</sec>
</body>
<back>
<fn-group content-type="conflict-of-interest">
  <title>Conflict of Interest</title>
  <fn fn-type="conflict">
<p>The authors declare that they have no conflicts of interest.</p>
  </fn>
</fn-group>
<fn-group content-type="ethics-statement">
  <title>Ethics Statement</title>
  <fn fn-type="ethics">
<p>This study did not require formal ethics approval.</p>
  </fn>
</fn-group>
<fn-group content-type="data-availability">
  <title>Data Availability</title>
  <fn fn-type="data-availability-statement">
<p>Data sharing is not applicable to this article.</p>
  </fn>
</fn-group>
<app-group>
  <app id="app-suppl">
    <title>Supplementary Materials</title>
<supplementary-material id="suppl-pdf" content-type="pdf" xlink:href="https://giidrjournal.com/pdf/giidr/FpOlz9KwB6.pdf">
  <label>PDF</label>
  <caption>
    <title>Full Text PDF</title>
  </caption>
</supplementary-material>
  </app>
</app-group>
<ref-list>
  <title>References</title>
<ref id="Akhtar">
  <label>1</label>
  <mixed-citation publication-type="journal">
    <year>2016</year>
    <source>Akhtar, S., Khan,
Z., Rafiq, M., &amp; Khan, A. (2016). Prevalence of type II d</source>
    <page-range>revalence</page-range>
    Akhtar, S., Khan,
Z., Rafiq, M., &amp; Khan, A. (2016). Prevalence of type II d
  </mixed-citation>
</ref>
<ref id="Branch">
  <label>2</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Branch, M., German, C., Bertoni, A., &amp; Yeboah, J</person-group>
    <year>2019</year>
    <source>
Incremental risk of cardiovascular disease and/or chronic kidney</source>
    Branch, M., German, C., Bertoni, A., &amp; Yeboah, J. (2019).
Incremental risk of cardiovascular disease and/or chronic kidney
  </mixed-citation>
</ref>
<ref id="Centers">
  <label>3</label>
  <mixed-citation publication-type="journal">
    <source>Centers for Disease Control and
Prevention, National diabetes fact sheet: national estimates and general
information on diabetes and prediabetes in the United States, Atlanta, Ga, USA,
2011</source>
    <page-range>revention</page-range>
    Centers for Disease Control and
Prevention, National diabetes fact sheet: national estimates and general
information on diabetes and prediabetes in the United States, Atlanta, Ga, USA,
2011.
  </mixed-citation>
</ref>
<ref id="Dal">
  <label>4</label>
  <mixed-citation publication-type="journal">
    <year>2019</year>
    <source>Dal
Canto, E., Ceriello, A., Rydén, L., Ferrini, M., Hansen, T. B., Schnell, O.,
&amp; Beulens, J. W. (2019). Diabetes as a cardiovascular risk factor: An
overview of global trends of macro and micro vascular complications. Europ</source>
    Dal
Canto, E., Ceriello, A., Rydén, L., Ferrini, M., Hansen, T. B., Schnell, O.,
&amp; Beulens, J. W. (2019). Diabetes as a cardiovascular risk factor: An
overview of global trends of macro and micro vascular complications. Europ
  </mixed-citation>
</ref>
<ref id="Einarson">
  <label>5</label>
  <mixed-citation publication-type="journal">
    <year>2018</year>
    <article-title>Einarson, T</article-title>
    <source>R., Acs, A., Ludwig, C.,
&amp; Panton, U. H. (2018). Prevalence of cardiovascular disease in type 2
diabetes: a systematic literature review of scientific evidence from across the
world in 2007–2017. Cardiovascular diabetology, 17,
1-19</source>
    <page-range>anton</page-range>
    Einarson, T. R., Acs, A., Ludwig, C.,
&amp; Panton, U. H. (2018). Prevalence of cardiovascular disease in type 2
diabetes: a systematic literature review of scientific evidence from across the
world in 2007–2017. Cardiovascular diabetology, 17,
1-19.
  </mixed-citation>
</ref>
<ref id="Gu">
  <label>6</label>
  <mixed-citation publication-type="journal">
    <year>1999</year>
    <article-title>Gu, K., Cowie, C</article-title>
    <source>C., &amp; Harris, M.
I. (1999). Diabetes and decline in heart disease mortality in US adults. Jama, 281(14),
1291-12979</source>
    <volume>281</volume>
    <issue>14</issue>
    <fpage>1291</fpage>
    <lpage>12979</lpage>
    Gu, K., Cowie, C. C., &amp; Harris, M.
I. (1999). Diabetes and decline in heart disease mortality in US adults. Jama, 281(14),
1291-12979.
  </mixed-citation>
</ref>
<ref id="Haffner">
  <label>7</label>
  <mixed-citation publication-type="journal">
    <year>2003</year>
    <article-title>Haffner, S</article-title>
    <source>J., &amp; Cassells, H.
(2003). Hyperglycemia as a cardiovascular risk factor. The American
journal of medicine, 115(8), 6-11</source>
    <volume>115</volume>
    <issue>8</issue>
    <fpage>6</fpage>
    <lpage>11</lpage>
    Haffner, S. J., &amp; Cassells, H.
(2003). Hyperglycemia as a cardiovascular risk factor. The American
journal of medicine, 115(8), 6-11.
  </mixed-citation>
</ref>
<ref id="Haq">
  <label>8</label>
  <mixed-citation publication-type="journal">
    <year>2024</year>
    <source>Haq,
B. U., Khan, Z., Khan, S., Ullah, U., &amp; Rashid, H. U. (2024)</source>
    Haq,
B. U., Khan, Z., Khan, S., Ullah, U., &amp; Rashid, H. U. (2024).
  </mixed-citation>
</ref>
<ref id="Hayward">
  <label>10</label>
  <mixed-citation publication-type="journal">
    <year>2015</year>
    <article-title>Hayward, R</article-title>
    <source>A., Reaven, P. D., Wiitala,
W. L., Bahn, G. D., Reda, D. J., Ge, L., &amp; Emanuele, N. V. (2015).
Follow-up of glycemic control and cardiovascular outcomes in type 2
diabetes. New England journal of medicine, 372(23),
2197-2206</source>
    <volume>372</volume>
    <issue>23</issue>
    <fpage>2197</fpage>
    <lpage>2206</lpage>
    Hayward, R. A., Reaven, P. D., Wiitala,
W. L., Bahn, G. D., Reda, D. J., Ge, L., &amp; Emanuele, N. V. (2015).
Follow-up of glycemic control and cardiovascular outcomes in type 2
diabetes. New England journal of medicine, 372(23),
2197-2206.
  </mixed-citation>
</ref>
<ref id="Khan">
  <label>11</label>
  <mixed-citation publication-type="journal">
    <year>2022</year>
    <source>Khan,
Z., &amp; Ali, A. (2022). Anemia and its Causes among Children in District Dir
Lower Applying Ranked Set Sampling Method for Data Collection. Research
Journal of Social Sciences and Economics Review, 3(4), 3</source>
    <volume>3</volume>
    <issue>4</issue>
    <fpage>3</fpage>
    Khan,
Z., &amp; Ali, A. (2022). Anemia and its Causes among Children in District Dir
Lower Applying Ranked Set Sampling Method for Data Collection. Research
Journal of Social Sciences and Economics Review, 3(4), 3
  </mixed-citation>
</ref>
<ref id="Leon">
  <label>16</label>
  <mixed-citation publication-type="journal">
    <year>2015</year>
    <article-title>Leon, B</article-title>
    <source>M., &amp; Maddox, T. M.
(2015). Diabetes and cardiovascular disease: epidemiology, biological
mechanisms, treatment recommendations and future research. World
journal of diabetes, 6(13), 1246</source>
    <volume>6</volume>
    <issue>13</issue>
    <fpage>1246</fpage>
    Leon, B. M., &amp; Maddox, T. M.
(2015). Diabetes and cardiovascular disease: epidemiology, biological
mechanisms, treatment recommendations and future research. World
journal of diabetes, 6(13), 1246.
  </mixed-citation>
</ref>
<ref id="Malmberg">
  <label>17</label>
  <mixed-citation publication-type="journal">
    <year>2000</year>
    <article-title>Malmberg, K., Yusuf, S., Gerstein, H</article-title>
    <source>C., Brown, J., Zhao, F., Hunt, D., &amp; Investigators, F. T. O. R. (2000).
Impact of diabetes on long-term prognosis in patients with unstable angina and
non–Q-wave myocardial infarction: results of the OASIS (Organization to Assess
Strategies f</source>
    <page-range>rognosis</page-range>
    Malmberg, K., Yusuf, S., Gerstein, H.
C., Brown, J., Zhao, F., Hunt, D., &amp; Investigators, F. T. O. R. (2000).
Impact of diabetes on long-term prognosis in patients with unstable angina and
non–Q-wave myocardial infarction: results of the OASIS (Organization to Assess
Strategies f
  </mixed-citation>
</ref>
<ref id="Matheus">
  <label>18</label>
  <mixed-citation publication-type="journal">
    <year>2013</year>
    <article-title>Matheus, A</article-title>
    <source>S. D. M., Tannus, L. R. M.,
Cobas, R. A., Palma, C. C. S., Negrato, C. A., &amp; Gomes, M. D. B. (2013).
Impact of diabetes on cardiovascular disease: an update. International
journal of hypertension, 2013</source>
    <page-range>alma</page-range>
    Matheus, A. S. D. M., Tannus, L. R. M.,
Cobas, R. A., Palma, C. C. S., Negrato, C. A., &amp; Gomes, M. D. B. (2013).
Impact of diabetes on cardiovascular disease: an update. International
journal of hypertension, 2013.
  </mixed-citation>
</ref>
<ref id="Petrie">
  <label>19</label>
  <mixed-citation publication-type="journal">
    <year>2018</year>
    <article-title>Petrie, J</article-title>
    <source>R., Guzik, T. J., &amp;
Touyz, R. M. (2018). Diabetes, hypertension, and cardiovascular disease:
clinical insights and vascular mechanisms. Canadian Journal of
Cardiology, 34(5), 575-584</source>
    <volume>34</volume>
    <issue>5</issue>
    <fpage>575</fpage>
    <lpage>584</lpage>
    Petrie, J. R., Guzik, T. J., &amp;
Touyz, R. M. (2018). Diabetes, hypertension, and cardiovascular disease:
clinical insights and vascular mechanisms. Canadian Journal of
Cardiology, 34(5), 575-584.
  </mixed-citation>
</ref>
<ref id="Raza">
  <label>20</label>
  <mixed-citation publication-type="journal">
    <year>2019</year>
    <article-title>Raza, S</article-title>
    <source>A., Hassan,
M., Badar, F., Rasheed, F., Meerza, F., Azam, S., &amp; Islam, N. (2019).
Cardiovascular disease risk factors in</source>
    Raza, S. A., Hassan,
M., Badar, F., Rasheed, F., Meerza, F., Azam, S., &amp; Islam, N. (2019).
Cardiovascular disease risk factors in
  </mixed-citation>
</ref>
<ref id="Regassa">
  <label>21</label>
  <mixed-citation publication-type="journal">
    <year>2021</year>
    <article-title>Regassa, L</article-title>
    <source>D., Tola, A., &amp; Ayele,
Y. (2021). Prevalence of cardiovascular disease and associated factors among
type 2 diabetes patients in selected hospitals of Harari region, eastern
Ethiopia. Frontiers in Public Health, 8, 532719</source>
    <page-range>revalence</page-range>
    Regassa, L. D., Tola, A., &amp; Ayele,
Y. (2021). Prevalence of cardiovascular disease and associated factors among
type 2 diabetes patients in selected hospitals of Harari region, eastern
Ethiopia. Frontiers in Public Health, 8, 532719.
  </mixed-citation>
</ref>
<ref id="Tamiru">
  <label>22</label>
  <mixed-citation publication-type="journal">
    <year>2010</year>
    <source>Tamiru, S., &amp;
Alemseged, F. (2010). Risk factors for cardiovascular diseases among diabetic
patients in southwest Ethiopia. </source>
    <page-range>atients</page-range>
    Tamiru, S., &amp;
Alemseged, F. (2010). Risk factors for cardiovascular diseases among diabetic
patients in southwest Ethiopia. 
  </mixed-citation>
</ref>
<ref id="Tracey">
  <label>23</label>
  <mixed-citation publication-type="journal">
    <year>2015</year>
    <source>Tracey,
M. L., Gilmartin, M., O’Neill, K., Fitzgerald, A. P., McHugh, S. M., Buckley,
C. M., &amp; Kearney, P. M. (2015). Epidemiology of diabetes and complications
among adults in the Republic of Ireland 1998-2015: a systematic review a</source>
    <page-range>M</page-range>
    Tracey,
M. L., Gilmartin, M., O’Neill, K., Fitzgerald, A. P., McHugh, S. M., Buckley,
C. M., &amp; Kearney, P. M. (2015). Epidemiology of diabetes and complications
among adults in the Republic of Ireland 1998-2015: a systematic review a
  </mixed-citation>
</ref>
<ref id="Wang">
  <label>24</label>
  <mixed-citation publication-type="journal">
    <year>2021</year>
    <source>Wang, C., Ye, D., Xie,
Z., Huang, X., Wang, Z., Shangguan, H., &amp; Wang, S. (2021). Assessment of
cardiovascular risk factors and th</source>
    Wang, C., Ye, D., Xie,
Z., Huang, X., Wang, Z., Shangguan, H., &amp; Wang, S. (2021). Assessment of
cardiovascular risk factors and th
  </mixed-citation>
</ref>
<ref id="Yao">
  <label>25</label>
  <mixed-citation publication-type="journal">
    <year>2023</year>
    <source>Yao, X., Zhang, J., Zhang, X., Jiang,
T., Zhang, Y., Dai, F., &amp; Zhang, Q. (2023). Age at diagnosis, diabetes
duration and the risk of cardiovascular disease in patients with diabetes
mellitus: a cross-sectional study. Frontiers in Endocrinology, 14,
113139</source>
    <page-range>atients</page-range>
    Yao, X., Zhang, J., Zhang, X., Jiang,
T., Zhang, Y., Dai, F., &amp; Zhang, Q. (2023). Age at diagnosis, diabetes
duration and the risk of cardiovascular disease in patients with diabetes
mellitus: a cross-sectional study. Frontiers in Endocrinology, 14,
113139
  </mixed-citation>
</ref>
<ref id="Zoungas">
  <label>26</label>
  <mixed-citation publication-type="journal">
    <year>2014</year>
    <source>Zoungas,
S., Woodward, M., Li, Q., Cooper, M. E., Hamet, P., Harrap, S., &amp; ADVANCE
Collaborative Group. (2014). Impact of age, age at diagnosis and duration of
diabetes on the risk of macrovascular and microvascular complications and death
in typ</source>
    Zoungas,
S., Woodward, M., Li, Q., Cooper, M. E., Hamet, P., Harrap, S., &amp; ADVANCE
Collaborative Group. (2014). Impact of age, age at diagnosis and duration of
diabetes on the risk of macrovascular and microvascular complications and death
in typ
  </mixed-citation>
</ref>
</ref-list>
</back>
</article>